Rifadin Kit
NDC Package 0068-0660-50

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Rifadin (rifampicin) kits is 3. This formulation utilizes a kit delivery system. Marketed by Sanofi-aventis U.s. Llc, this product is identified by NDC 0068-0660.

Identification & Billing

NDC Package Code
0068-0660-50
Package Description
1 KIT in 1 CARTON * 10 mL in 1 VIAL (0068-0600-01) * 10 mL in 1 AMPULE (0068-0610-10)
Product Code
0068-0660
11-Digit Billing Format
00068066050

Clinical Specifications

Proprietary Name
Rifadin
Non-Proprietary Name
Rifampicin
Dosage Form
Kit - A packaged collection of related material.
Usage Information
3. How Rifadin Infusion is givenRifadin Infusion is given by a doctor or nurse. This is because it needs to be given as a slow drip into a vein (infusion).

Regulatory & Marketing

Labeler Name
Sanofi-aventis U.s. Llc
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE -
Start Marketing Date
08-03-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0068-0660-50 identifies a specific commercial package of 1 kit in 1 carton * 10 ml in 1 vial (0068-0600-01) * 10 ml in 1 ampule (0068-0610-10) of Rifadin, a human prescription drug labeled by Sanofi-aventis U.s. Llc. This kit is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sanofi-aventis U.s. Llc on August 03, 2026. The current certification is valid through December 31, 2027.

How is this Sanofi-aventis U.s. Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00068066050. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0068-0660-50
11-Digit CMS (5-4-2)
00068-0660-50

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.